Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

Sky TV's satellite switch: A close call averted
Markets Opinion

Peter Griffin: Sky TV's satellite switch: A close call averted

It looks like Sky TV has just one last major satellite switch-over to navigate.

Peter Griffin 16 Apr 2025
Perennial asset class learnings
Opinion

David Chaplin: Perennial asset class learnings

The demand for private equity (of multiple shades) and private debt is soaring.

David Chaplin 15 Apr 2025
A geo-strategic model is now front and centre
Markets Opinion

Cameron Bagrie: A geo-strategic model is now front and centre

A geo-strategic model is in the driving seat. 

Cameron Bagrie 14 Apr 2025
The unlikely way Trump is helping
Economy Opinion

Pattrick Smellie: The unlikely way Trump is helping

The Trump tariff blitz is creating political opportunity in unlikely places.

Pattrick Smellie 14 Apr 2025